Recent published hypertension guidelines: A critical approach

Published:April 27, 2019DOI:
      Since 2012, doctors encountered a tsunami of new guidelines in the field of hypertension. >8 guidelines have been published by different societies or groups, causing confusion not only among general practitioners, but also among experts. However, if we look into the literature, no new drugs for the treatment of blood pressure (BP) have been released and only a few randomized clinical trials have taken place, which leads to the conclusion that all the data being used in these guidelines are coming from these randomized clinical trials, post-hoc analyses of large outcome trials, registries, as well as meta-analyses clinical trials.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Angeli F.
        • Reboldi G.
        • Trapasso M.
        • Gentile G.
        • Pinzagli M.G.
        • Aita A.
        • et al.
        European and US guidelines for arterial hypertension: similarities and differences.
        Eur J Intern Med. 2019; (S0953-6205:30040-8)
        • Williams B.
        • Mancia G.
        • Spiering W.
        • Agabiti Rosei E.
        • Azizi M.
        • Burnier M.
        • et al.
        ESC/ESH guidelines for the management of arterial hypertension.
        Eur Heart J. 2018; 39: 3021-3104
        • Whelton P.K.
        • Carey R.M.
        • Aronow W.S.
        • Casey Jr., D.E.
        • Collins K.J.
        • Dennison Himmelfarb C.
        • et al.
        ACC/AHA/AAPA/ABC/ACPM,AGS/APhA/ASH/ASPC/NMA/PCNA guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guideline.
        J Am Coll Cardiol. 2017; 71 (2018): e127-e248
        • James P.A.
        • Oparil S.
        • Carter B.L.
        • Cushman W.C.
        • Dennison-Himmelfarb C.
        • Handler J.
        • et al.
        Evidence-based guideline for the management of high blood pressure in adults: report from panel members appointed to the Eight Joint National Committee (JNC 8).
        JAMA. 2014; 311: 507-520
        • SPRINT Research Group
        • Wright Jr., J.T.
        • Williamson J.D.
        • Whelton P.K.
        • Snyder J.K.
        • Sink K.M.
        • et al.
        A randomized trial of intense versus standard blood-pressure control.
        N Engl J Med. 2015; 373: 2103-2116
        • Kjeldsen S.
        • Mancia G.
        A critical review of the systolic blood pressure intervention trial (SPRINT).
        Eur Heart J. 2017; 38: 3260-3265
        • Tsika E.P.
        • Poulimenos L.E.
        • Boudoulas K.D.
        • Manolis A.J.
        The J-curve in arterial hypertension: fact or fallacy?.
        Cardiology. 2014; 129: 126-135
        • de Boer I.H.
        • Bangalore S.
        • Benetos A.
        • Davis A.M.
        • Michos E.D.
        • Muntner P.
        • et al.
        Diabetes Care. 2017; 40: 1273-1284
        • Nauman M.D.
        • Goldstein J.N.
        • Cirullo M.A.
        • Schwartz J.S.
        Durability of class I American College of Cardiology/American Heart Association clinical practice guidelines recommendations.
        JAMA. 2014; 311: 2092-2100